account_balance
Investment manager · 13F filer · SEC CIK 1953107
Enavate Sciences Gp, LLC
Reported value$345Mas of Jun 30, 2026
Positions7 0 new, 0 sold out
Top 10 weight100.0%SION alone is 32%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 7 stocks.
SIONSionna Therapeutics Inc
31.6%
ZBIOZenas Biopharma Inc
28.8%
IMNMImmunome Inc
22.2%
BBOTBridgebio Oncology Therapeut
5.8%
CMPXCompass Therapeutics Inc
4.9%
UPBUpstream Bio Inc
4.9%
CAMPSIONSionna Therapeutics Inc
31.6%
ZBIOZenas Biopharma Inc
28.8%
IMNMImmunome Inc
22.2%
BBOT5.8%CMPX4.9%UPB4.9%CAMPBox size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed